Cite
MLA Citation
R. Alten et al.. “OP0152 Effects of Tofacitinib Monotherapy versus Methotrexate on Patient-Reported Outcomes in the 2-Year Phase 3 Oral Start TRIAL in Methotrexate-NaÏVe Patients with Rheumatoid Arthritis.” Annals of the rheumatic diseases, vol. 73, 2014, pp. 118–119. http://access.bl.uk/ark:/81055/vdc_100135166269.0x000059